Costs Associated with Nontuberculous Mycobacteria Infection, Ontario, Canada, 2001–2012
To determine incidence-based healthcare costs attributable to nontuberculous mycobacterial (NTM) pulmonary disease (PD) and NTM pulmonary isolation (PI), from the healthcare payer perspective, we conducted a population-based matched cohort study in Ontario, Canada. We established cohorts of patients...
Main Authors: | Lauren C. Ramsay, Emily Shing, John Wang, Theodore K. Marras, Jeffrey C. Kwong, Sarah K. Brode, Frances B. Jamieson, Beate Sander |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2020-09-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/26/9/19-0524_article |
Similar Items
-
Pulmonary Infection and Colonization with Nontuberculous Mycobacteria, Taiwan, 2000–2012
by: Jung-Yien Chien, et al.
Published: (2014-08-01) -
Pulmonary Nontuberculous Mycobacteria, Ontario, Canada, 2020
by: Theodore K. Marras, et al.
Published: (2023-07-01) -
Identification and characterization of nontuberculous mycobacteria isolated from suspected pulmonary tuberculosis patients in eastern china from 2009 to 2019 using an identification array system
by: Yelei Zhu, et al.
Published: (2022-03-01) -
Nontuberculous mycobacteria isolated from specimens of pulmonary tuberculosis suspects, Northern Tunisia: 2002–2016
by: Reem Gharbi, et al.
Published: (2019-09-01) -
Safety and effectiveness of low-dose amikacin in nontuberculous mycobacterial pulmonary disease treated in Toronto, Canada
by: Maria Luisa Aznar, et al.
Published: (2019-06-01)